Is ATEC a good stock to buy? We came across a bearish thesis on Alphatec Holdings, Inc. on Valueinvestorsclub.com by lc_fund. In this article, we will summarize the bears’ thesis on ATEC. Alphatec Holdings, Inc.’s share was trading at $13.05 as of March 17th. ATEC’s forward P/E was 63.69 according to Yahoo Finance.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Additionally, a large portion of its target population—patients with spinal stenosis or herniated discs—either do not require fusion or are better served with decompression procedures, reducing the effective total addressable market to roughly $6 billion, ~42% below bullish estimates. Regulatory pressures, such as CMS’s WISER AI-driven pre-authorization for outpatient fusions, further constrain volumes, particularly as outpatient procedures have grown from 2% to 26% of the market.
Competitor products have reached technological parity, with ATEC lagging in surgical robotics and overall device functionality, undermining its prior moat and limiting future case growth. The newly launched Valence robot is less capable than offerings from Medtronic, Globus, and Vista, and adoption is expected to be slow. Recent growth was largely driven by elevated sales commissions, which are now being normalized; combined with low switching costs, this suggests significant sales rep churn in FY’26, directly threatening surgical volume and market share.
Valuation multiples are likely to compress as ATEC faces decelerating sales growth, pricing pressure, and shrinking market opportunities, with a base-case target price of $14.2 implying ~33% downside from current levels. Risks such as product improvements or slower-than-expected churn appear limited, making Alphatec a high-conviction short with substantial downside relative to its current market price.
Previously, we covered a bullish thesis on Medtronic plc (MDT) by Investing Intel in May 2025, which highlighted strong organic revenue growth, broad-based segment performance, and the planned spin-off of its diabetes business to unlock value and improve margins. MDT’s stock price has appreciated by approximately 9.61% since our coverage. lc_fund shares a contrarian view but emphasizes Alphatec Holdings, Inc.’s (ATEC) structural headwinds, limited market opportunity, product parity, and sales rep churn, indicating notable downside risk.
Alphatec Holdings, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 47 hedge fund portfolios held ATEC at the end of the fourth quarter which was 40 in the previous quarter. While we acknowledge the risk and potential of ATEC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ATEC and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
